Search
for
Sort by
Research 721–750 of 1000+
- Dermatological drugs, topical agents, and cosmetics
- Cytostatics and immunosuppressive drugs
- Dermatologic therapy: December 1986 to December 1987
- PHILADELPHIA DERMATOLOGICAL SOCIETY
- Queries and Minor Notes
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- Complications in Esthetic Surgery
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Visually scoring hirsutism
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Anatomy and Physiology of the Skin
- Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D
- The Rotterdam Study: 2012 objectives and design update
- Hair and scalp dermatoscopy
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic